BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/26/2020 8:54:27 AM | Browse: 675 | Download: 1200
 |
Received |
|
2020-08-28 23:43 |
|
Peer-Review Started |
|
2020-08-28 23:43 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-10-05 23:14 |
|
Revised |
|
2020-10-12 17:49 |
|
Second Decision |
|
2020-11-06 08:24 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-11-10 17:35 |
|
Articles in Press |
|
2020-11-10 17:35 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-11-23 12:13 |
|
Publish the Manuscript Online |
|
2020-11-26 08:54 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Nso Nso, Daniel Antwi-Amoabeng, Bryce D Beutler, Mark B Ulanja, Jasmine Ghuman, Ahmed Hanfy, Joyce Nimo-Boampong, Sirri Atanga, Rajkumar Doshi, Sostanie Enoru and Nageshwara Gullapalli |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Bryce D Beutler, MD, Doctor, Doctor, Department of Radiology, University of Southern California, Keck School of Medicine, 1500 San Pablo St., 2nd Floor, Los Angeles, CA 90033, United States. brycebeutler@hotmail.com |
| Key Words |
Atrial fibrillation; Cancer; Immune checkpoint inhibitors; Immunotherapy; Cardiovascular adverse events; Pericardial effusion |
| Core Tip |
Cardiovascular immune-related adverse events (irAEs) are rare but potentially life-threatening complications that can occur in patients receiving immune checkpoint inhibitor (ICI) therapy. The most common ICI-associated adverse events are atrial fibrillation, myocarditis, and pericardial effusion. Risk factors for cardiovascular irAEs include treatment with combination immunotherapy, male sex, and a history of cardiac disease. Ongoing post-market surveillance is imperative to characterize long-term risks and improve outcomes among patients receiving ICIs. |
| Publish Date |
2020-11-26 08:54 |
| Citation |
Nso N, Antwi-Amoabeng D, Beutler BD, Ulanja MB, Ghuman J, Hanfy A, Nimo-Boampong J, Atanga S, Doshi R, Enoru S, Gullapalli N. Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis. World J Cardiol 2020; 12:(11): 584-598 |
| URL |
https://www.wjgnet.com/1949-8462/full/v12/i11/584.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v12.i11.584 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
